CMIRX | NRGEX | CMIRX / NRGEX | |
Total Expense Ratio | 1.25 | 0.03 | 4,167% |
Annual Report Gross Expense Ratio | 8.13 | 0.69 | 1,178% |
Fund Existence | 4 years | 4 years | - |
Gain YTD | 13.433 | -0.885 | -1,517% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 5M | 9.1B | 0% |
Annual Yield % from dividends | 0.00 | 0.53 | - |
Returns for 1 year | 23.91 | -1.80 | -1,326% |
Returns for 3 years | 23.58 | 10.22 | 231% |
Returns for 5 years | N/A | N/A | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PYPG | 15.78 | 0.07 | +0.44% |
Leverage Shares 2X Long PYPL Daily ETF | |||
ADME | 50.61 | 0.16 | +0.32% |
Aptus Drawdown Managed Equity ETF | |||
STRV | 42.70 | 0.12 | +0.29% |
Strive 500 ETF | |||
FMED | 24.39 | -0.20 | -0.81% |
Fidelity Disruptive Medicine ETF | |||
CRSH | 3.27 | -0.12 | -3.54% |
YieldMax Short TSLA Option Income Strategy ETF |